China

China Clinical Trial Quote Request

Yes

Unknown

3 months

THE PROCESS TO ISSUE DOCUMENTS IS SLOW. China is a cash for cover country, meaning payment must be made PRIOR to the release of documentation. Please allow 2-3 weeks for documentation to be issued

• Clinical Trial Quote Request Form
• Protocol and Informed Consent in English
• Protocol Title in Chinese
• Legal Representative or Local CRO contact information (Contact Person Name, Address, Telephone Number and E-Mail Address). The Legal Representative is named on the Policy. The Sponsor is the Additional Insured
• Provide the Business License of Sponsor
• Provide the Business License pf Chinese CRO
• Provide the ID Copy of representative of Chinese CRO
• Premium payments are paid directly by the Sponsor to the carrier. No refund for policy cancellation
• Only Policies are typically issued in China. If the EC requests a Certificate to be issued, the Insurer will provide

n/a

OFAC RESTRICTED COUNTRY - NO CLINICAL TRIAL COVERAGE ALLOWED

Significant sanctions remain in respect of Cuba. For example, Group remain subject to a range of financial, export, procurement, and other US sanctions if it:

(i) does business with Cuban or Cuba-related entities or individuals that appear on the US Treasury Department’s List of Specially Designated Nationals and Blocked Persons (known as the “SDN List”);
(ii) does business that involves movement of targeted goods between the US and Cuba.

Therefore the detailed characteristics of each and every transaction must be clearly understood, documented and checked against the full range of financial crime and sanctions tools before any assessment can be made as to whether business can be conducted.

No Group entity domiciled in the US, no US employee, citizen, permanent resident, shareholder, investor, or any other form of US business partner can be involved in any way in undertaking or engaging business with Cuba unless covered by a general license. No items relating to Cuba can be tabled or discussed with any such parties unless covered by a general license. It is Hyperion’s responsibility and, in particular, those undertaking such business transactions, to ensure that this prohibition is maintained.

n/a

n/a

n/a